Investing in ATMP: From Breakthroughs to Scalable Therapies

ATMP is at an inflection point, where significant scientific progress is now meeting increasing expectations on scalability, cost, and commercial viability. This creates a growing need for stronger alignment across the ecosystem – bringing together developers, investors, technology providers, and enabling organizations.

This joint event, hosted by CCRM Nordic and ATMP Flemmingsberg, is a dedicated investor-focused session designed to connect capital with the ATMP ecosystem. It offers a unique opportunity for investors to gain a structured understanding of the field, explore the latest developments, and engage directly with companies and experts shaping the future of cell and gene therapy.

Who should attend?

• Investors who are either new or experienced in ATMP
• Developers of ATMPs and supportive technology

Why attend?

• Get experts view of where the ATMP field is today – and where it is heading
• Understand what has changed in recent years and what still remains challenging
• Learn what makes an ATMP company investable
• Explore technologies enabling scalability
• Connect directly with leading companies and investors in the space

Event details

Date: Monday, November 30th 2026
Location: Auditorium at Campus Flemingsberg, Stockholm
Time: 13:00 – 18:00

View the agenda and register your interest at CCRM Nordic through the button below.